J2L: (4S)-8-(methanesulfonyl)-2,3-dimethyl-6-{2-[1-methyl-3-(pyrrolidin-1-yl)-1H-1,2,4-triazol-5-yl]ethyl}imidazo[1,2-b]pyridazine
J2L is a Ligand Of Interest in 5SH3 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5SH3_J2L_C_803 | 95% | 3% | 0.079 | 0.983 | 2.66 | 3.33 | 7 | 10 | 1 | 0 | 100% | 1 |
| 5SH3_J2L_D_803 | 94% | 17% | 0.078 | 0.977 | 1.53 | 2.07 | 4 | 6 | 0 | 0 | 100% | 1 |
| 5SH3_J2L_B_803 | 89% | 8% | 0.087 | 0.966 | 1.54 | 3.07 | 6 | 6 | 1 | 0 | 100% | 1 |
| 5SH3_J2L_A_803 | 84% | 4% | 0.113 | 0.974 | 1.9 | 3.71 | 7 | 9 | 1 | 0 | 100% | 0.5 |
